Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis
<a href="https://pixabay.com/users/fernandozhiminaicela/">fernandozhiminaicela</a> / Pixabay

Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

According to a story from finanzen.at, the biotechnology company Orbsen Therapeutics recently announced that its immunotherapy product ORBCEL-C is to be tested in a multi-site clinical trial called MERLIN that…

Continue Reading
Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU
<a href="https://pixabay.com/users/fernandozhiminaicela/">fernandozhiminaicela</a> / Pixabay

Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU

According to a story from Market Screener, the specialty pharmaceutical company Santhera Pharmaceuticals recently released an announcement in which the company revealed its intent to file for Conditional Marketing Authorization…

Continue Reading
Close Menu